Additional molecular studies are needed to further investigate the cooperation between Rab members, their effectors and established oncogenic events in order to reconcile discrepancies between tumor suppressors versus promoter activity of Rab25 in HNSCC. This evidence concerns the gene RAB25 and head and neck squamous cell carcinoma.